The mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma: a network pharmacology, molecular docking, and experimental study

Abstract Objective To elucidate the potential targets and mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma (OSCC) through network pharmacology and molecular docking, supported by clinical data and in vitro experiments. Methods Potential targets of Brucea javanica and OS...

Full description

Saved in:
Bibliographic Details
Main Authors: MingKang Li, Juan Zhan, YiHan Lai, YuJie Ma, HongCheng Wei, Lin Jiang, JuanJuan Zha, YiSen Shao, Wei Wang
Format: Article
Language:English
Published: BMC 2025-06-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-025-02686-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850137740975276032
author MingKang Li
Juan Zhan
YiHan Lai
YuJie Ma
HongCheng Wei
Lin Jiang
JuanJuan Zha
YiSen Shao
Wei Wang
author_facet MingKang Li
Juan Zhan
YiHan Lai
YuJie Ma
HongCheng Wei
Lin Jiang
JuanJuan Zha
YiSen Shao
Wei Wang
author_sort MingKang Li
collection DOAJ
description Abstract Objective To elucidate the potential targets and mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma (OSCC) through network pharmacology and molecular docking, supported by clinical data and in vitro experiments. Methods Potential targets of Brucea javanica and OSCC-related disease targets were identified via the TCMSP, GeneCards, and OMIM databases. A Venn diagram was employed to obtain the intersection targets, which were considered as the potential targets for Brucea javanica in OSCC treatment. The protein–protein interaction (PPI) network was constructed using the STRING database and Cytoscape 3.7.2 to identify core targets. Gene ontology (GO) function enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the intersection targets were conducted using the Metascape database. Molecular docking between the main components of Brucea javanica and core targets was performed using AutoDockTools software. The expression of core targets in clinical samples was analyzed via the GEO database. Finally, the effects of Brucea javanica oil (BJO) on OSCC proliferation, invasion, and migration, as well as the expression of the EGFR/PI3K/AKT signaling pathway, were verified in vitro. Results A total of 60 potential targets of Brucea javanica against OSCC were identified, with β-sitosterol and luteolin selected as the primary active components. The five targets with the highest connectivity, AKT1, CASP3, PTGS2, TP53, and EGFR, were identified as core targets. KEGG pathway analysis indicated that the anti-OSCC effects of Brucea javanica are primarily mediated through the PI3K-AKT signaling pathway, JAK-STAT signaling pathway, etc. Molecular docking studies demonstrated strong binding affinities between the main components of Brucea javanica and its core targets. Analysis of clinical samples revealed elevated expression levels of core targets in OSCC samples compared to normal samples. The CCK-8 assay and colony formation assay indicated that BJO effectively inhibited OSCC cell proliferation. The scratch test and Transwell test showed that BJO could inhibit the invasion and migration of oral squamous cell carcinoma. In addition, Western blot and RT-qPCR showed that BJO could down-regulate the expression of EGFR/PI3K/AKT signaling pathway-related proteins and mRNA. Conclusion Brucea javanica exhibits multi-target and multi-pathway characteristics in the treatment of oral squamous cell carcinoma, potentially exerting its anti-cancer effects by inhibiting the EGFR/PI3K/AKT signaling pathway.
format Article
id doaj-art-dd7b57af7aea417a94b97359575c48cd
institution OA Journals
issn 2047-783X
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj-art-dd7b57af7aea417a94b97359575c48cd2025-08-20T02:30:45ZengBMCEuropean Journal of Medical Research2047-783X2025-06-0130111010.1186/s40001-025-02686-1The mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma: a network pharmacology, molecular docking, and experimental studyMingKang Li0Juan Zhan1YiHan Lai2YuJie Ma3HongCheng Wei4Lin Jiang5JuanJuan Zha6YiSen Shao7Wei Wang8Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangxi University of Chinese MedicineDepartment of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangxi University of Chinese MedicineDepartment of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangxi University of Chinese MedicineThe Affiliated Stomatological Hospital, Jiangxi Medical College, Nanchang UniversityThe Affiliated Stomatological Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangxi University of Chinese MedicineDepartment of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangxi University of Chinese MedicineDepartment of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangxi University of Chinese MedicineDepartment of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangxi University of Chinese MedicineAbstract Objective To elucidate the potential targets and mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma (OSCC) through network pharmacology and molecular docking, supported by clinical data and in vitro experiments. Methods Potential targets of Brucea javanica and OSCC-related disease targets were identified via the TCMSP, GeneCards, and OMIM databases. A Venn diagram was employed to obtain the intersection targets, which were considered as the potential targets for Brucea javanica in OSCC treatment. The protein–protein interaction (PPI) network was constructed using the STRING database and Cytoscape 3.7.2 to identify core targets. Gene ontology (GO) function enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the intersection targets were conducted using the Metascape database. Molecular docking between the main components of Brucea javanica and core targets was performed using AutoDockTools software. The expression of core targets in clinical samples was analyzed via the GEO database. Finally, the effects of Brucea javanica oil (BJO) on OSCC proliferation, invasion, and migration, as well as the expression of the EGFR/PI3K/AKT signaling pathway, were verified in vitro. Results A total of 60 potential targets of Brucea javanica against OSCC were identified, with β-sitosterol and luteolin selected as the primary active components. The five targets with the highest connectivity, AKT1, CASP3, PTGS2, TP53, and EGFR, were identified as core targets. KEGG pathway analysis indicated that the anti-OSCC effects of Brucea javanica are primarily mediated through the PI3K-AKT signaling pathway, JAK-STAT signaling pathway, etc. Molecular docking studies demonstrated strong binding affinities between the main components of Brucea javanica and its core targets. Analysis of clinical samples revealed elevated expression levels of core targets in OSCC samples compared to normal samples. The CCK-8 assay and colony formation assay indicated that BJO effectively inhibited OSCC cell proliferation. The scratch test and Transwell test showed that BJO could inhibit the invasion and migration of oral squamous cell carcinoma. In addition, Western blot and RT-qPCR showed that BJO could down-regulate the expression of EGFR/PI3K/AKT signaling pathway-related proteins and mRNA. Conclusion Brucea javanica exhibits multi-target and multi-pathway characteristics in the treatment of oral squamous cell carcinoma, potentially exerting its anti-cancer effects by inhibiting the EGFR/PI3K/AKT signaling pathway.https://doi.org/10.1186/s40001-025-02686-1Brucea javanica oilOral squamous cell carcinomaSignaling pathwayNetwork pharmacology
spellingShingle MingKang Li
Juan Zhan
YiHan Lai
YuJie Ma
HongCheng Wei
Lin Jiang
JuanJuan Zha
YiSen Shao
Wei Wang
The mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma: a network pharmacology, molecular docking, and experimental study
European Journal of Medical Research
Brucea javanica oil
Oral squamous cell carcinoma
Signaling pathway
Network pharmacology
title The mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma: a network pharmacology, molecular docking, and experimental study
title_full The mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma: a network pharmacology, molecular docking, and experimental study
title_fullStr The mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma: a network pharmacology, molecular docking, and experimental study
title_full_unstemmed The mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma: a network pharmacology, molecular docking, and experimental study
title_short The mechanisms of Brucea javanica in the treatment of oral squamous cell carcinoma: a network pharmacology, molecular docking, and experimental study
title_sort mechanisms of brucea javanica in the treatment of oral squamous cell carcinoma a network pharmacology molecular docking and experimental study
topic Brucea javanica oil
Oral squamous cell carcinoma
Signaling pathway
Network pharmacology
url https://doi.org/10.1186/s40001-025-02686-1
work_keys_str_mv AT mingkangli themechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT juanzhan themechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT yihanlai themechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT yujiema themechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT hongchengwei themechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT linjiang themechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT juanjuanzha themechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT yisenshao themechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT weiwang themechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT mingkangli mechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT juanzhan mechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT yihanlai mechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT yujiema mechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT hongchengwei mechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT linjiang mechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT juanjuanzha mechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT yisenshao mechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy
AT weiwang mechanismsofbruceajavanicainthetreatmentoforalsquamouscellcarcinomaanetworkpharmacologymoleculardockingandexperimentalstudy